These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
36. Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. Fosse E; Moen O; Johnson E; Semb G; Brockmeier V; Mollnes TE; Fagerhol MK; Venge P Ann Thorac Surg; 1994 Aug; 58(2):472-7. PubMed ID: 8067851 [TBL] [Abstract][Full Text] [Related]
37. Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices. Baksaas ST; Videm V; Pedersen T; Karlsen H; Mollnes TE; Brosstad F; Svennevig JL Perfusion; 1999 Mar; 14(2):119-27. PubMed ID: 10338323 [TBL] [Abstract][Full Text] [Related]
38. Effects of methylprednisolone and a biocompatible copolymer circuit on blood activation during cardiopulmonary bypass. Rubens FD; Nathan H; Labow R; Williams KS; Wozny D; Karsh J; Ruel M; Mesana T Ann Thorac Surg; 2005 Feb; 79(2):655-65. PubMed ID: 15680854 [TBL] [Abstract][Full Text] [Related]
39. Descending thoracic aortic aneurysm repair with the aid of partial cardiopulmonary bypass: heparin-coated circuits versus nonheparin-coated circuits. Morishita K; Kawaharada N; Fukada J; Hachiro Y; Kurimoto Y; Fujisawa Y; Saito T; Abe T Artif Organs; 2005 Apr; 29(4):300-5. PubMed ID: 15787624 [TBL] [Abstract][Full Text] [Related]
40. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits. Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]